127 related articles for article (PubMed ID: 17566333)
1. Development and validation of a stability-indicating liquid chromatographic method for determination of emtricitabine and related impurities in drug substance.
Seshachalam U; Haribabu B; Chandrasekhar KB
J Sep Sci; 2007 May; 30(7):999-1004. PubMed ID: 17566333
[TBL] [Abstract][Full Text] [Related]
2. HPLC method for the determination of emtricitabine and related degradation substances.
Hamarapurkar PD; Parate AN
J Chromatogr Sci; 2013; 51(5):419-24. PubMed ID: 23051064
[TBL] [Abstract][Full Text] [Related]
3. A validated HPLC stability-indicating method for the determination of diacerhein in bulk drug substance.
Giannellini V; Salvatore F; Bartolucci G; Coran SA; Bambagiotti-Alberti M
J Pharm Biomed Anal; 2005 Sep; 39(3-4):776-80. PubMed ID: 15955656
[TBL] [Abstract][Full Text] [Related]
4. UPLC and LC-MS studies on degradation behavior of irinotecan hydrochloride and development of a validated stability-indicating ultra-performance liquid chromatographic method for determination of irinotecan hydrochloride and its impurities in pharmaceutical dosage forms.
Kumar N; Sangeetha D; Reddy SP
J Chromatogr Sci; 2012 Oct; 50(9):810-9. PubMed ID: 22661461
[TBL] [Abstract][Full Text] [Related]
5. HPLC method development, validation, and impurity characterization of a potent antitumor nucleoside, T-dCyd (NSC 764276).
Liu M; Wang J; Liu P
J Pharm Biomed Anal; 2016 Nov; 131():429-435. PubMed ID: 27661436
[TBL] [Abstract][Full Text] [Related]
6. Development of a stability- indicating HPLC method for simultaneous determination of ten related substances in vonoprazan fumarate drug substance.
Luo Z; Liu A; Liu Y; Wang G; Chen X; Wang H; Li M; Zhang H; Qiu Y; Zhai H
J Pharm Biomed Anal; 2018 Feb; 149():133-142. PubMed ID: 29112902
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a novel stability-indicating HPLC method for the quantitative determination of eleven related substances in ezetimibe drug substance and drug product.
Luo Z; Deng Z; Liu Y; Wang G; Yang W; Hou C; Tang M; Yang R; Zhou H
Talanta; 2015 Jul; 139():67-74. PubMed ID: 25882410
[TBL] [Abstract][Full Text] [Related]
8. A validated stability-indicating RP-HPLC method for levofloxacin in the presence of degradation products, its process related impurities and identification of oxidative degradant.
Lalitha Devi M; Chandrasekhar KB
J Pharm Biomed Anal; 2009 Dec; 50(5):710-7. PubMed ID: 19632800
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of an LC method for the determination of emtricitabine and related compounds in the drug substance.
Ashenafi D; Verbeek A; Hoogmartens J; Adams E
J Sep Sci; 2009 Jun; 32(11):1823-30. PubMed ID: 19425024
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of an UPLC method for rapid determination of ibuprofen and diphenhydramine citrate in the presence of impurities in combined dosage form.
Rao DD; Sait SS; Mukkanti K
J Chromatogr Sci; 2011 Apr; 49(4):281-6. PubMed ID: 21439118
[TBL] [Abstract][Full Text] [Related]
11. ICH guidance in practice: establishment of inherent stability of secnidazole and development of a validated stability-indicating high-performance liquid chromatographic assay method.
Bakshi M; Singh S
J Pharm Biomed Anal; 2004 Nov; 36(4):769-75. PubMed ID: 15533669
[TBL] [Abstract][Full Text] [Related]
12. A validated specific stability-indicating RP-HPLC assay method for Ambrisentan and its related substances.
Narayana MB; Chandrasekhar KB; Rao BM
J Chromatogr Sci; 2014 Sep; 52(8):818-25. PubMed ID: 23926121
[TBL] [Abstract][Full Text] [Related]
13. Robust and Rugged Stability-Indicating HPLC Method for the Determination of Plerixafor and Its Related Impurities in Drug Substances.
Bapatu HR; Maram RK; Murthy RS
J Chromatogr Sci; 2015 Oct; 53(9):1432-42. PubMed ID: 25858970
[TBL] [Abstract][Full Text] [Related]
14. Validation of a high-performance liquid chromatography method for the assay of and determination of related organic impurities in nevirapine drug substance.
Li QC; Tougas T; Cohen K; Lee R; Meagan P; Corson M; Muchnick T
J Chromatogr Sci; 2000 Jun; 38(6):246-54. PubMed ID: 10890748
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a stability indicating RP-HPLC method for the simultaneous determination of related substances of albuterol sulfate and ipratropium bromide in nasal solution.
Kasawar GB; Farooqui M
J Pharm Biomed Anal; 2010 May; 52(1):19-29. PubMed ID: 20045275
[TBL] [Abstract][Full Text] [Related]
16. A novel and rapid validated stability-indicating UPLC method of related substances for dorzolamide hydrochloride and timolol maleate in ophthalmic dosage form.
Sharma N; Rao SS; Reddy AM
J Chromatogr Sci; 2012 Oct; 50(9):745-55. PubMed ID: 22562819
[TBL] [Abstract][Full Text] [Related]
17. Quantification of potential impurities by a stability indicating UV-HPLC method in niacinamide active pharmaceutical ingredient.
Thomas S; Bharti A; Tharpa K; Agarwal A
J Pharm Biomed Anal; 2012 Feb; 60():86-90. PubMed ID: 22115882
[TBL] [Abstract][Full Text] [Related]
18. Determination of nelfinavir mesylate as bulk drug and in pharmaceutical dosage form by stability indicating HPLC.
Jing Q; Shen Y; Tang Y; Ren F; Yu X; Hou Z
J Pharm Biomed Anal; 2006 Jun; 41(3):1065-9. PubMed ID: 16545536
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of a stability-indicating high performance liquid chromatographic (HPLC) assay for biperiden in bulk form and pharmaceutical dosage forms.
Mohammadi A; Mehramizi A; Moghaddam FA; Jabarian LE; Pourfarzib M; Kashani HN
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jul; 854(1-2):152-7. PubMed ID: 17466605
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of a stability-indicating RP-HPLC method for the simultaneous estimation of process related impurities and degradation products of rasagiline mesylate in pharmaceutical formulation.
Reddy PS; Sudhakar Babu K; Kumar N
J Chromatogr Sci; 2013 Mar; 51(3):242-9. PubMed ID: 22988002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
